CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
diet, sodium-restricted (Phase III) diet, sodium-restricted +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000528
NCT00000528Phase 3Completed
CompareCT.gov

Trials of Hypertension Prevention (TOHP)

National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated Mar 16, 2016

In Brief

A Phase 3 clinical trial evaluating diet, sodium-restricted (Phase III) diet, sodium-restricted and diet, reducing (Phase III) for Cardiovascular Diseases and 3 related conditions. Completed.

Detailed Summary

To determine if nonpharmacological interventions, including diet and lifestyle change, could prevent increases in arterial blood pressure leading to systemic hypertension.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Heart Diseases, Hypertension, Vascular Diseases
Countries--
Collaborators--

Timeline

Phase 3CompletedFinished
198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 28, 1999
Enrollment StartSep 1, 1986
Study CompletionJun 1, 1998
TodayJul 2, 2026
Posted 26.7 years ago

Interventions

diet, sodium-restricted (Phase III) diet, sodium-restrictedbehavioral

diet, reducing (Phase III)behavioral